Project Grant F32AI186459
Award Date
12/4/25
Completion Date
7/31/28
Dollars Obligated
$151K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award of $868,776.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to characterize a novel post-transcriptional regulator in the opportunistic pathogen Pseudomonas aeruginosa. The key objectives are to: Identify the direct regulatory targets of the RNA-binding protein PhaF under standard lab conditions, infection-relevant conditions, and in clinical isolates to...
The Scripps Research Institute was awarded a $779,915 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 5-year grant, effective May 5, 2025, will support research to investigate the chromatin remodeling functions of polyphosphate condensates in the opportunistic pathogen Pseudomonas aeruginosa. The project aims to define the relationship between polyphosphate, a stress-responsive...
This $849,713 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to elucidate RNA-RNA interaction networks during interbacterial interactions involving the bacterium Pseudomonas aeruginosa. The research team at Boston Children's Hospital seeks to define the small RNA (sRNA) interaction network in P. aeruginosa and decode the regulatory roles played by sRNAs during its interactions with other bacteria. The project will...
This $105,076 Project Grant was awarded on December 20, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The grant supports research conducted by Trustees of Dartmouth College to investigate the dual function of the TSIT immunity protein in regulating Pseudomonas aeruginosa biofilm production, which is a key challenge in treating chronic respiratory infections in cystic fibrosis...
This Project Grant award of $427,625.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research by Washington University to discover novel anti-biofilm agents derived from bacteriophages. The goal is to develop alternative therapies for treating biofilm-associated infections, which are a major challenge for pathogens like Pseudomonas aeruginosa. The research will isolate phages that can overcome biofilm barriers,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $453,629 to Yale University to conduct research on the cell surface of the opportunistic pathogen Pseudomonas aeruginosa. The project, titled "Phage-Seq Phenotyping of the Pseudomonas aeruginosa Surface-ome", aims to develop a high-throughput technology called "Phage-Seq" that can survey bacterial cell surfaces and...
This $198,630 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to characterize porin mutations and expand the capabilities of the BADLOCK CRISPR-based diagnostic test. The goal is to improve diagnostic capacity for antibiotic-resistant bacterial infections, especially carbapenem-resistant Enterobacterales, in resource-limited settings. Key activities include...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $794,849 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Cedars-Sinai Medical Center. The grant will fund research to investigate mechanisms of cefiderocol resistance and cross-protection in Pseudomonas aeruginosa, a common lung infection in cystic fibrosis patients. Key objectives include determining how mutations in the CpxS two-component sensor system impact siderophore...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $205,000 to The Trustees of Princeton University to conduct research examining the influence of chromosome copy number on Pseudomonas aeruginosa persisters to fluoroquinolone antibiotics. The research aims to fill knowledge gaps in understanding persistence to this antibiotic class in this opportunistic pathogen that...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $422,355 in funding to Virginia Polytechnic Institute & State University (Virginia Tech) to conduct mechanistic studies on the signaling histidine kinase GacS from the nosocomial pathogen Pseudomonas aeruginosa. The research aims to experimentally validate predicted conformational changes in GacS upon...